Annual ROE
-129.63%
+4.86%+3.61%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual return on equity is -129.63%, with the most recent change of +4.86% (+3.61%) on December 31, 2023.
- During the last 3 years, CAPR annual ROE has fallen by -51.68% (-66.30%).
- CAPR annual ROE is now -106.77% below its all-time high of 1915.43%, reached on December 31, 2006.
Performance
CAPR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-143.31%
+117.96%+45.15%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly return on equity is -143.31%, with the most recent change of +117.96% (+45.15%) on September 30, 2024.
- Over the past year, CAPR quarterly ROE has increased by +117.96% (+45.15%).
- CAPR quarterly ROE is now -105.62% below its all-time high of 2550.65%, reached on June 30, 2007.
Performance
CAPR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CAPR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | +45.1% |
| 3 y3 years | -66.3% | -0.7% |
| 5 y5 years | +32.4% | -0.7% |
CAPR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.8% | +3.6% | -137.7% | +66.3% |
| 5 y | 5-year | -92.8% | +3.6% | -162.8% | +66.3% |
| alltime | all time | -106.8% | +68.2% | -105.6% | +97.0% |
Capricor Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -143.31%(-45.1%) |
| Jun 2024 | - | -261.27%(+3.6%) |
| Mar 2024 | - | -252.29%(-6.0%) |
| Dec 2023 | -129.63%(-3.6%) | -268.28%(-37.0%) |
| Sep 2023 | - | -425.56%(+59.8%) |
| Jun 2023 | - | -266.28%(+41.2%) |
| Mar 2023 | - | -188.63%(+32.5%) |
| Dec 2022 | -134.49%(+100.0%) | -142.32%(+31.4%) |
| Sep 2022 | - | -108.31%(+25.3%) |
| Jun 2022 | - | -86.46%(+23.9%) |
| Mar 2022 | - | -69.81%(+15.8%) |
| Dec 2021 | -67.23%(-13.8%) | -60.29%(+10.5%) |
| Sep 2021 | - | -54.54%(-3.0%) |
| Jun 2021 | - | -56.21%(-8.4%) |
| Mar 2021 | - | -61.38%(-4.1%) |
| Dec 2020 | -77.95%(-41.6%) | -64.00%(-4.1%) |
| Sep 2020 | - | -66.71%(-16.6%) |
| Jun 2020 | - | -80.02%(-42.0%) |
| Mar 2020 | - | -138.04%(-23.7%) |
| Dec 2019 | -133.42%(-30.4%) | -180.83%(-18.4%) |
| Sep 2019 | - | -221.72%(+1.3%) |
| Jun 2019 | - | -218.83%(+10.7%) |
| Mar 2019 | - | -197.72%(+11.9%) |
| Dec 2018 | -191.78%(-384.9%) | -176.69%(-3324.3%) |
| Sep 2018 | - | 5.48%(-87.3%) |
| Jun 2018 | - | 43.22%(-86.8%) |
| Mar 2018 | - | 326.83%(-329.2%) |
| Dec 2017 | 67.32%(-85.7%) | -142.57%(-154.6%) |
| Sep 2017 | - | 261.05%(-31.9%) |
| Jun 2017 | - | 383.26%(-14.4%) |
| Mar 2017 | - | 447.84%(-39.6%) |
| Dec 2016 | 469.79%(-62.3%) | 740.92%(-24.6%) |
| Sep 2016 | - | 982.18%(-14.4%) |
| Jun 2016 | - | 1147.03%(-296.5%) |
| Mar 2016 | - | -583.69%(-40.8%) |
| Dec 2015 | 1246.10%(+1152.5%) | -985.25%(-46.9%) |
| Sep 2015 | - | -1854.18%(-46.7%) |
| Jun 2015 | - | -3475.86%(-764.0%) |
| Mar 2015 | - | 523.51%(+225.6%) |
| Dec 2014 | 99.49%(-124.4%) | 160.79%(-54.4%) |
| Sep 2014 | - | 352.52%(-29.8%) |
| Jun 2014 | - | 502.13%(-27.8%) |
| Mar 2014 | - | 695.56%(-114.3%) |
| Dec 2013 | -407.93%(+463.8%) | -4851.16%(+188.8%) |
| Sep 2013 | - | -1679.69%(+202.3%) |
| Jun 2013 | - | -555.70%(+106.7%) |
| Mar 2013 | - | -268.86%(+69.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -72.36%(-74.6%) | -158.71%(-62.1%) |
| Sep 2012 | - | -419.02%(+54.4%) |
| Jun 2012 | - | -271.46%(+2.0%) |
| Mar 2012 | - | -266.26%(+17.1%) |
| Dec 2011 | -285.03%(+31.8%) | -227.34%(+49.6%) |
| Sep 2011 | - | -151.94%(+1.0%) |
| Jun 2011 | - | -150.38%(-21.7%) |
| Mar 2011 | - | -192.14%(-3.9%) |
| Dec 2010 | -216.22%(+11.0%) | -199.88%(-3.2%) |
| Sep 2010 | - | -206.41%(-11.9%) |
| Jun 2010 | - | -234.22%(-19.8%) |
| Mar 2010 | - | -291.89%(+28.8%) |
| Dec 2009 | -194.72%(+50.5%) | -226.63%(+6.8%) |
| Sep 2009 | - | -212.13%(+12.7%) |
| Jun 2009 | - | -188.28%(+25.1%) |
| Mar 2009 | - | -150.49%(+17.1%) |
| Dec 2008 | -129.35%(-5.4%) | -128.51%(+28.3%) |
| Sep 2008 | - | -100.18%(-25.2%) |
| Jun 2008 | - | -134.01%(-3.8%) |
| Mar 2008 | - | -139.24%(-13.5%) |
| Dec 2007 | -136.78%(-107.1%) | -160.89%(-36.0%) |
| Sep 2007 | - | -251.20%(-109.8%) |
| Jun 2007 | - | 2550.65%(+44.6%) |
| Mar 2007 | - | 1764.52%(+33.2%) |
| Dec 2006 | 1915.43%(+7763.0%) | 1324.35%(+48.3%) |
| Sep 2006 | - | 893.28%(+2581.7%) |
| Jun 2006 | - | 33.31%(+20.5%) |
| Mar 2006 | - | 27.65%(+2.7%) |
| Dec 2005 | 24.36%(-20.9%) | 26.91%(-16.5%) |
| Sep 2005 | - | 32.23%(-8.5%) |
| Jun 2005 | - | 35.23%(-8.8%) |
| Mar 2005 | - | 38.63%(+4.8%) |
| Dec 2004 | 30.78%(-22.7%) | 36.86%(+15.6%) |
| Sep 2004 | - | 31.88%(+20.8%) |
| Jun 2004 | - | 26.39%(-32.1%) |
| Mar 2004 | - | 38.86%(-16.4%) |
| Dec 2003 | 39.80%(-37.5%) | 46.48%(-1.9%) |
| Sep 2003 | - | 47.40%(-44.2%) |
| Jun 2003 | - | 85.00%(-28.6%) |
| Mar 2003 | - | 119.02%(+14.8%) |
| Dec 2002 | 63.67%(-74.6%) | 103.65%(-20.8%) |
| Sep 2002 | - | 130.94%(-2.9%) |
| Jun 2002 | - | 134.87%(+13.4%) |
| Mar 2002 | - | 118.97%(-52.3%) |
| Dec 2001 | 250.56%(-192.0%) | 249.44% |
| Dec 2000 | -272.39%(-917.3%) | - |
| Dec 1999 | 33.33% | - |
FAQ
- What is Capricor Therapeutics annual return on equity?
- What is the all time high annual ROE for Capricor Therapeutics?
- What is Capricor Therapeutics annual ROE year-on-year change?
- What is Capricor Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly ROE year-on-year change?
What is Capricor Therapeutics annual return on equity?
The current annual ROE of CAPR is -129.63%
What is the all time high annual ROE for Capricor Therapeutics?
Capricor Therapeutics all-time high annual return on equity is 1915.43%
What is Capricor Therapeutics annual ROE year-on-year change?
Over the past year, CAPR annual return on equity has changed by +4.86% (+3.61%)
What is Capricor Therapeutics quarterly return on equity?
The current quarterly ROE of CAPR is -143.31%
What is the all time high quarterly ROE for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly return on equity is 2550.65%
What is Capricor Therapeutics quarterly ROE year-on-year change?
Over the past year, CAPR quarterly return on equity has changed by +117.96% (+45.15%)